| scholarly article | Q13442814 |
| P2093 | author name string | Seong Who Kim | |
| Hyun Jin Choi | |||
| Onyou Hwang | |||
| So Yeon Lee | |||
| P2860 | cites work | Oxygen toxicity, oxygen radicals, transition metals and disease | Q29615096 |
| Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. | Q36899240 | ||
| Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. | Q41029391 | ||
| Oxidative stress and the pathogenesis of Parkinson's disease | Q41262986 | ||
| Neuronal vulnerability in Parkinson's disease. | Q41446817 | ||
| Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione | Q72109104 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| dopamine | Q170304 | ||
| cytotoxicity | Q246181 | ||
| sapropterin | Q419808 | ||
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 143-152 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease | |
| P478 | volume | 86 |
| Q53203837 | A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models. |
| Q36147318 | A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP. |
| Q39993979 | A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells |
| Q36123780 | A novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model |
| Q38869276 | Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease |
| Q38603276 | Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues |
| Q37482974 | Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta |
| Q37260391 | Approaches to prevent dopamine quinone-induced neurotoxicity |
| Q48481582 | Cyclooxygenase-independent neuroprotective effects of aspirin against dopamine quinone-induced neurotoxicity |
| Q37622166 | Developmental susceptibility of neurons to transient tetrahydrobiopterin insufficiency and antenatal hypoxia-ischemia in fetal rabbits |
| Q37717851 | Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease |
| Q37629253 | Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity |
| Q45937480 | Doxycycline is neuroprotective against nigral dopaminergic degeneration by a dual mechanism involving MMP-3. |
| Q36702899 | Early infant exposure to excess multivitamin: a risk factor for autism? |
| Q46514011 | Glia cell number modulates sensitivity to MPTP in mice |
| Q39064885 | Inactivation of Aconitase by Tetrahydrobiopterin in DArgic Cells: Relevance to PD. |
| Q38907367 | Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models |
| Q52677431 | Interaction of genetic and environmental factors in a Drosophila parkinsonism model. |
| Q90732124 | Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis |
| Q36285084 | L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease |
| Q92662264 | Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease |
| Q33883174 | Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress |
| Q34217427 | Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice |
| Q36607332 | Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation |
| Q38645013 | Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease |
| Q64067591 | Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP⁺-Induced Cell Damage |
| Q24684947 | Sepiapterin reductase expression is increased in Parkinson's disease brain tissue |
| Q47103259 | Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation |
| Q57697189 | Transcriptomic signatures of schizophrenia revealed by dopamine perturbation in an ex vivo model |
| Q39686769 | p38(MAPK)/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration |
Search more.